Zura Bio appoints Michael Howell as chief scientific officer

Zura Bio announced the appointment of Michael Howell to the role of chief scientific officer and head of translational science. Howell brings more than two decades of experience leading discovery, translational research, and early clinical programs and will lead the scientific strategy and translational science efforts at Zura Bio. Howell initially joined Zura Bio in 2022 as a scientific advisor during the company’s formation and acquisition of its first two clinical programs.